Trends in the use of disease-modifying therapies among reproductive-aged women with multiple sclerosis in the United States from 2010 to 2019.

Emilie D Duchesneau Alan C KinlawMichele Jonsson FunkVirginia PateJennifer L Lund

Published in: Pharmacoepidemiology and drug safety (2022)

DMT use among reproductive-aged women has rapidly evolved during the past decade. Collaborative treatment decision making between women with MS and clinicians may help optimize MS care and improve DMT uptake during reproductive years.

Keyphrases

multiple sclerosis
mass spectrometry
decision making
palliative care
ms ms
quality improvement
healthcare
white matter
polycystic ovary syndrome
pain management
pregnant women
adipose tissue
skeletal muscle
combination therapy
chronic pain
breast cancer risk